Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
Wall Street
Price Targets
Price Targets Summary
Taisho Pharmaceutical Holdings Co Ltd
According to Wall Street analysts, the average 1-year price target for Taisho Pharmaceutical Holdings Co Ltd is 5 600 JPY .
Revenue
Forecast
Revenue Estimate
Taisho Pharmaceutical Holdings Co Ltd
For the last 8 years the compound annual growth rate for Taisho Pharmaceutical Holdings Co Ltd's revenue is 0%. The projected CAGR for the next 3 years is 2%.
Operating Income
Forecast
Operating Income Estimate
Taisho Pharmaceutical Holdings Co Ltd
For the last 8 years the compound annual growth rate for Taisho Pharmaceutical Holdings Co Ltd's operating income is -4%. The projected CAGR for the next 2 years is 3 091%.
Net Income
Forecast
Net Income Estimate
Taisho Pharmaceutical Holdings Co Ltd
For the last 8 years the compound annual growth rate for Taisho Pharmaceutical Holdings Co Ltd's net income is -3%. The projected CAGR for the next 3 years is -9%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Taisho Pharmaceutical Holdings Co Ltd's stock price target?
Price Target
5 600
JPY
According to Wall Street analysts, the average 1-year price target for Taisho Pharmaceutical Holdings Co Ltd is 5 600 JPY .
What is Taisho Pharmaceutical Holdings Co Ltd's Revenue forecast?
Projected CAGR
2%
For the last 8 years the compound annual growth rate for Taisho Pharmaceutical Holdings Co Ltd's revenue is 0%. The projected CAGR for the next 3 years is 2%.
What is Taisho Pharmaceutical Holdings Co Ltd's Operating Income forecast?
Projected CAGR
3 091%
For the last 8 years the compound annual growth rate for Taisho Pharmaceutical Holdings Co Ltd's operating income is -4%. The projected CAGR for the next 2 years is 3 091%.
What is Taisho Pharmaceutical Holdings Co Ltd's Net Income forecast?
Projected CAGR
-9%
For the last 8 years the compound annual growth rate for Taisho Pharmaceutical Holdings Co Ltd's net income is -3%. The projected CAGR for the next 3 years is -9%.